Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 308 followers
Latest posts
Last updated 7 minutes ago
Eli Lilly in talks over $1.3B deal for gene editing partner Verve Therapeutics: FT
7 minutes ago
Eli Lilly is in talks to buy gene editing partner Verve Therapeutics...
‘Have we no shame?’: Federal judge rules hundreds of NIH grant terminations must be restored
about 11 hours ago
A federal judge in Massachusetts has ruled that hundreds of grants terminated...
China proposes shorter clinical trial reviews in efforts to accelerate drug development
about 12 hours ago
China, already gaining speed in biotechnology, is looking to further accelerate novel...
Turkish private equity group invests $39M to support Harvard researcher’s next-gen obesity antibodies
about 16 hours ago
As Harvard University reels from extensive cuts to federal funding by the...
Sarepta reports 2nd death after DMD gene therapy Elevidys, stops dosing in half of patients
about 18 hours ago
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising...
Former CEO Anne Wojcicki prevails in 23andMe auction, with final $305M bid
about 19 hours ago
Her $305 million offer topped the previous frontrunner, Regeneron, which bid $256...
NextCure advances ADC pivot with $745M deal for Simcere’s phase 1 drug
about 19 hours ago
NextCure has ramped up its antibody-drug conjugate (ADC) pivot, penning a $745...
Gilead lays off 36 people after axing California expansion plan
about 19 hours ago
Gilead is laying off 36 people as part of the rethink that...
South Korean biotech’s GLP-1 drug scores MASH win, while reducing weight
about 22 hours ago
D&D Pharmatech tested a once-weekly regimen of its dual GLP1/glucagon receptor agonist...
Eli Lilly’s phase 1 amylin data impress analysts, pairing 11% weight loss with tolerable profile
1 day ago
Eli Lilly has shared phase 1 data on amylin analog eloralintide, impressing...
FDA’s ‘heavy workload’ blamed for delays to KalVista’s angioedema drug approval decision
1 day ago
KalVista Pharmaceuticals has become the latest biotech to face delays to the...
J&J hails 100% response rate in 10 patients for early-stage lymphoma CAR-T
4 days ago
Johnson and Johnson is providing a first look at clinical data for...